New hope for liver cancer patients who have run out of options
Disease control
Completed
This study tested whether the drug sorafenib could help control advanced liver cancer in patients whose disease had worsened after at least one prior treatment. Fifty participants took a daily pill and were monitored to see if the cancer stopped growing and how long they lived. T…
Phase: PHASE2 • Sponsor: Bo Hyun Kim • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC